216 related articles for article (PubMed ID: 35370936)
1. Prognostic Factors and Models for Elderly (≥70 Years Old) Primary Operable Triple-Negative Breast Cancer: Analysis From the National Cancer Database.
Tang Z; Ji Y; Min Y; Zhang X; Xu W; Zhao L; Zhang J; Long L; Feng J; Wen Y
Front Endocrinol (Lausanne); 2022; 13():856268. PubMed ID: 35370936
[TBL] [Abstract][Full Text] [Related]
2. Prognosis of Patients With Triple-negative Breast Cancer: A Population-based Study From SEER Database.
Zhou HL; Chen DD
Clin Breast Cancer; 2023 Apr; 23(3):e85-e94. PubMed ID: 36669957
[TBL] [Abstract][Full Text] [Related]
3. Identifying the Prognosis Factors and Predicting the Survival Probability in Patients with Non-Metastatic Chondrosarcoma from the SEER Database.
Huang R; Sun Z; Zheng H; Yan P; Hu P; Yin H; Zhang J; Meng T; Huang Z
Orthop Surg; 2019 Oct; 11(5):801-810. PubMed ID: 31663279
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive study of clinical features, prognostic factors, and survival in patients with pancreatic solid pseudopapillary neoplasms based on the 2019 WHO classification.
Luo W; Chen H; Wang J; Qiu J; Zhang T
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12393-12404. PubMed ID: 37438539
[TBL] [Abstract][Full Text] [Related]
5. Prognostic nomograms and Aggtrmmns scoring system for predicting overall survival and cancer-specific survival of patients with kidney cancer.
Zhou Y; Zhang R; Ding Y; Wang Z; Yang C; Tao S; Liang C
Cancer Med; 2020 Apr; 9(8):2710-2722. PubMed ID: 32087609
[TBL] [Abstract][Full Text] [Related]
6. Geriatric Early-Stage Triple-Negative Breast Cancer Patients in Low-risk Population: Omitting Chemotherapy Based on Nomogram.
Zhou C; Xu L; Du Z; Lv Q
Clin Breast Cancer; 2022 Dec; 22(8):771-780. PubMed ID: 36163127
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Factors and a Nomogram Predicting Overall Survival and Cancer-Specific Survival for Patients with Collecting Duct Renal Cell Carcinoma.
Xiao R; Liu C; He W; Ma L
Biomed Res Int; 2021; 2021():6736008. PubMed ID: 34805402
[TBL] [Abstract][Full Text] [Related]
8. Survival outcome assessment for triple-negative breast cancer: a nomogram analysis based on integrated clinicopathological, sonographic, and mammographic characteristics.
Sheng DL; Shen XG; Shi ZT; Chang C; Li JW
Eur Radiol; 2022 Oct; 32(10):6575-6587. PubMed ID: 35759017
[TBL] [Abstract][Full Text] [Related]
9. Influence of advanced age on the prognosis of triple-negative breast cancer patients: A surveillance, epidemiology, and end results-based study.
Tan H; Fu D
J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147967
[TBL] [Abstract][Full Text] [Related]
10. A Clinical Model of Bone Angiosarcoma Patients: A Population-based Analysis of Epidemiology, Prognosis, and Treatment.
Wang B; Chen LJ; Wang XY
Orthop Surg; 2020 Dec; 12(6):1652-1662. PubMed ID: 32914587
[TBL] [Abstract][Full Text] [Related]
11. Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis.
He X; Ji J; Dong R; Liu H; Dai X; Wang C; Esteva FJ; Yeung SJ
Breast Cancer Res Treat; 2019 Jan; 173(2):329-341. PubMed ID: 30341462
[TBL] [Abstract][Full Text] [Related]
12. Cancer-Specific Survival Outcome in Early-Stage Young Breast Cancer: Evidence From the SEER Database Analysis.
Liu R; Xiao Z; Hu D; Luo H; Yin G; Feng Y; Min Y
Front Endocrinol (Lausanne); 2021; 12():811878. PubMed ID: 35116010
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and Prognostic Nomograms for Lung Metastasis in Triple-Negative Breast Cancer.
Wang J; Zhao H; Ye L; Li J; Zhang H; Zhang C; Rao Q; Cai Y; Xu Y; Deng Y
Comput Math Methods Med; 2022; 2022():1750834. PubMed ID: 35991145
[TBL] [Abstract][Full Text] [Related]
14. Predicting Survival Benefit of Sparing Sentinel Lymph Node Biopsy in Low-Risk Elderly Patients With Early Breast Cancer: A Population-Based Analysis.
Xu L; Wen N; Qiu J; He T; Tan Q; Yang J; Du Z; Lv Q
Front Oncol; 2020; 10():1718. PubMed ID: 33042815
[No Abstract] [Full Text] [Related]
15. Prognosis in triple-negative apocrine carcinomas of the breast: A population-based study.
Wu W; Wu M; Peng G; Shi D; Zhang J
Cancer Med; 2019 Dec; 8(18):7523-7531. PubMed ID: 31642210
[TBL] [Abstract][Full Text] [Related]
16. Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer.
Feng Y; Wang Y; Xie Y; Wu S; Li Y; Li M
BMC Cancer; 2021 Apr; 21(1):450. PubMed ID: 33892663
[TBL] [Abstract][Full Text] [Related]
17. Evaluating anthracycline + taxane versus taxane-based chemotherapy in older women with node-negative triple-negative breast cancer: a SEER-Medicare study.
Schreiber AR; Kagihara J; Eguchi M; Kabos P; Fisher CM; Meyer E; Molina E; Kondapalli L; Bradley CJ; Diamond JR
Breast Cancer Res Treat; 2022 Jan; 191(2):389-399. PubMed ID: 34705147
[TBL] [Abstract][Full Text] [Related]
18. Metastasis Pattern and Survival Analysis in Primary Small Bowel Adenocarcinoma: A SEER-Based Study.
Gu Y; Deng H; Wang D; Li Y
Front Surg; 2021; 8():759162. PubMed ID: 34950695
[No Abstract] [Full Text] [Related]
19. Breast conserving surgery (BCS) with adjuvant radiation therapy showed improved prognosis compared with mastectomy for early staged triple negative breast cancer patients Running title: BCS had better prognosis than mastectomy for early TNBC patients.
Wang SE; Sun YD; Zhao SJ; Wei F; Yang G
Math Biosci Eng; 2019 Sep; 17(1):92-104. PubMed ID: 31731341
[No Abstract] [Full Text] [Related]
20. A prognostic model of patients with ovarian mucinous adenocarcinoma: a population-based analysis.
Yang L; Yu J; Zhang S; Shan Y; Li Y; Xu L; Zhang J; Zhang J
J Ovarian Res; 2022 Feb; 15(1):26. PubMed ID: 35168642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
